Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules

Blood

Volumn 88, Issue 10, 1996, Pages 4005-4011

  Foss, Hans Dieter ^a   Anagnostopoulos, Ioannis ^b   Araujo, Iguaracyra ^b   Assaf, Chalid ^b   Demel, Gudrun ^b   Kummer, J Alain ^b   Hummel, Michael ^b   Stein, Harald ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PERFORIN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANAPLASTIC CARCINOMA; ARTICLE; BETA CHAIN; CONTROLLED STUDY; GENE REARRANGEMENT; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; NULL CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; T CELL LYMPHOMA; T LYMPHOCYTE;

EID: 0029803574     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.10.4005.bloodjournal88104005     Document Type: Article

References (28)

1. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R: The expression of the Hodgkin's disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue - Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lyraphoid cells. Blood 66:848, 1985
2. Stein H, Dallenbach F: Diffuse large cell lymphomas of Band T-cell type, in Knowles DM (ed): Neoplastic Hematopathology. Baltimore, MD, Williams & Wilkins, 1992, p 675
3. Kadin ME: Primary Ki-1-positive anaplastic large-cell lymphoma: A distinct clinicopathological entity. Ann Oncol 5:S25, 1994(suppl 1)
4. Delsol G, Al Saati T, Gatter KC, Gerdes J, Schwarting R, Caveriviere P, Rigal-Huguet F, Robert A, Stein H, Mason DY: Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol 130:59, 1988
5. +) anaplastic large cell lymphomas. Morphologic, immunohistologic and clinical characteristics. Am J Pathol 135:359, 1989
6. Beljaards RC, Meijer CJ, Scheffer E, Toonstra J, Van-Vloten WA, van-der Putte SC, Geerts ML, Willemze R: Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients. Am J Pathol 135:1169, 1989
7. De Bruin PC, Beljaards RC, van Herde P, Van-der Valk P, Noorduyn LA, Van-Krieken JH, Kluin-Nelemans JC, Willemze R, Meijer CJ: Differences in the clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell and null-cell phenotype. Histopathology 23:127, 1993
8. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Müller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
9. Liu C-C, Walsh CM, Young JD-E: Perforin: Structure and function. Immunol Today 16:194, 1995
10. Shresta S, MacIvor DM, Heusel JW, Ley TJ: Natural killer cells and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc Natl Acad Sci USA 92:5679, 1995
11. Smyth MJ, Trapani JA: Granzymes: Exogenous proteinases that induce target cell apoptosis. Immunol Today 16:202, 1995
12. Darmon AJ, Nicholson DW, Bleackley RC: Activation of apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377:446, 1995
13. Lichtenheld MG, Podack ER: Structure of the human perforin gene. A simple gene organization with interesting potential regulatory sequences. J Immunol 143:4267, 1989
14. Jenne DE, Tschopp J: Granzymes: A family of serine proteases in granules of cytotoxic T-lymphocytes. Curr Top Microbiol Immunol 140:33, 1988
15. Kummer JA, Kamp AM, Tadema TM, Vos W, Meijer CJ, Hack CE: Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood. Clin Exp Immunol 100:164, 1995
16. Garcia-Sanz JA, MacDonald HR, Jenne DE, Tschopp J, Nabholz M: Cell specificity of granzyme gene expression. J Immunol 145:3111, 1990
17. Stein H, Gatter K, Asbahr H, Mason DY: Use of freeze-dried paraffin embedded sections for immunohistological staining with monoclonal antibodies. Lab Invest 52:676, 1985
18. Foss HD, Herbst H, Oelmann E, Samol J, Grebe M, Blankenstein T, Matthes J, Qin ZH, Falini B, Pileri S, Diamantstein T. Stein H: Lymphotoxin, tumor necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases. Br J Haematol 84:627, 1993
19. + T-helper cells. Am J Pathol 140:15, 1992
20. Foss HD, Herbst H, Hummel M, Araujo I, Latza U, Rancsò C, Dallenbach F, Stein H: Patterns of cytokine gene expression in infectious mononucleosis. Blood 83:707, 1994
21. Lessin SR, Rook AH, Rovera G: Molecular diagnosis of T-cell lymphoma: Polymerase chain reaction amplification of T-cell antigen receptor beta-chain gene rearrangements. J Invest Dermatol 96:299, 1991
22. Kneba M, Bolz I, Linke B, Hiddemann W: Analysis of rearranged T-cell receptor beta-chain genes by polymerase chain reaction (PCR), DNA sequencing and high resolution PCR fragment analysis. Blood 86:3930, 1995
23. + peripheral blood progenitor cells mobilized by chemotherapy and granulocyte colony-stimulating factor. Blood 86:3500, 1995
24. Spits H, Lanier L, Phillips JH: Development of human T and natural killer cells. Blood 85:2654, 1995
25. O'Connor NTJ, Stein H, Gatter KC, Wainscoat JS, Crick J, Al Saati T, Falini B, Delsol G, Mason DY: Genotypic analysis of large cell lymphomas which express the Ki-1 antigen. Histopathology 11:733, 1987
26. De Bruin PC, Kummer JA, van der Valk P, van Heerde P, Kluin PM, Willemze R, Ossenkoppele GJ, Radaszkiewicz T, Meijer CJLM: Granzyme B-expressing peripheral T-cell lymphomas: Neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization. Blood 84:3785, 1994
27. Herbst H, Anagnostopoulos I, Heinze B, Dürkop H, Hummel M, Stein H: ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. Blood 86:1694, 1995
28. Oudejans JJ, Kummer JA, Jiwa NM, van der Valk P, Ossenkoppele GJ, Kluin PM, Kluin-Nelemans JC, Meijer CJLM: Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol 148:233, 1996